Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Current Assets (2016 - 2025)

AtriCure (ATRC) has disclosed Current Assets for 16 consecutive years, with $322.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets rose 20.42% to $322.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $322.5 million, a 20.42% increase, with the full-year FY2025 number at $322.5 million, up 20.42% from a year prior.
  • Current Assets was $322.5 million for Q4 2025 at AtriCure, up from $301.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $322.5 million in Q4 2025 to a low of $195.7 million in Q3 2021.
  • A 5-year average of $246.8 million and a median of $248.4 million in 2024 define the central range for Current Assets.
  • Biggest YoY gain for Current Assets was 134.84% in 2021; the steepest drop was 36.08% in 2021.
  • AtriCure's Current Assets stood at $196.1 million in 2021, then grew by 9.76% to $215.2 million in 2022, then rose by 23.71% to $266.2 million in 2023, then grew by 0.59% to $267.8 million in 2024, then increased by 20.42% to $322.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Current Assets are $322.5 million (Q4 2025), $301.1 million (Q3 2025), and $271.3 million (Q2 2025).